We found that presence of LPS at subclinical levels, typical for ME, enhances the malignant phenotype of TLR4-expressing BC cells, and in parallel, adversely activates host-derived cells infiltrating the tumor tissue. This evidence concerns the gene TLR4 and breast cancer.